2,904
Views
3
CrossRef citations to date
0
Altmetric
Clinical Study

Evaluation of cerebral dysfunction in patients with chronic kidney disease using neuropsychometric and neurophysiological tests

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 577-584 | Received 02 Jan 2021, Accepted 06 Mar 2021, Published online: 24 Mar 2021

References

  • Levin A, Tonelli M, Bonventre J, et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet. 2017;390:1830–1888.
  • Burn DJ, Bates D. Neurology and the kidney [Review]. J Neurol Neurosurg Psychiatry. 1998;65:810–821.
  • Olano CG, Akram SM, Bhatt H. Uremic encephalopathy. Treasure Island (FL): StatPearls Publishing; 2021.
  • Vanholder R, De Smet R, Glorieux G, et al., For the European Uremic Toxin Work Group (EUTox). Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 2003;63:1934–1943.
  • Kim DM, Lee IH, Song CJ. Uremic encephalopathy: MR imaging findings and clinical correlation. Am J Neuroradiol. 2016;37(9):1604–1609.
  • Hocker SE. Renal disease and neurology. Continuum (Minneapolis, Minn.). 2017;23:722–743.
  • Young GB, Angel MJ. Uremic encephalopathy. Encyclopedia of the Neurological Sciences. 2014;4:587–588.
  • Ridola L, Cardinale V, Riggio O. The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies. Ann Gastroenterol. 2018;31:151–164.
  • Seifter JL, Samuels MA. Uremic encephalopathy and other brain disorders associated with renal failure. Semin Neurol. 2011;31:139–143.
  • Bajaj JS, Lauridsen M, Tapper EB, et al. Important unresolved questions in the management of hepatic encephalopathy: An ISHEN Consensus. Am J Gastroenterol. 2020;115:989–1002.
  • Ampuero J, Montoliú C, Simón-Talero M, et al. Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression. J Gastroenterol Hepatol. 2018;33:718–725.
  • Nardone R, Taylor AC, Höller Y, et al. Minimal hepatic encephalopathy: a review. Neurosci Res. 2016;111:1–12.
  • Rose CF, Amodio P, Bajaj JS, et al. Hepatic encephalopathy: novel insights into classification, pathophysiology and therapy. J Hepatol. 2020;73:1526–1547.
  • Bajaj JS, Pinkerton SD, Sanyal AJ, et al. Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: a cost-effectiveness analysis. Hepatology (Baltimore, Md.). 2012;55:1164–1171.
  • Amodio P, Campagna F, Olianas S, et al. Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study. J Hepatol. 2008;49:346–353.
  • Duarte-Rojo A, Estradas J, Hernández-Ramos R, et al. Validation of the psychometric hepatic encephalopathy score (PHES) for identifying patients with minimal hepatic encephalopathy. Dig Dis Sci. 2011;56:3014–3023.
  • Sharma P, Sharma BC, Puri V, et al. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol. 2007;47:67–73.
  • Sharma P, Sharma BC, Sarin SK. Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis. Hepatobiliary Pancreat Dis Int. 2010;9:27–32.
  • Romero-Gómez M, Córdoba J, Jover R, et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology. 2007;45:879–885.
  • Barone M, Shahini E, Iannone A, et al. Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis. Dig Liver Dis. 2018;50:496–500.
  • Esmat S, Garem NE, Raslan H, et al. Critical flicker frequency is diagnostic of minimal hepatic encephalopathy. J Investig Med. 2017;65:1131–1135.
  • Torlot FJ, McPhail MJW, Taylor-Robinson SD. Meta-analysis: the diagnostic accuracy of critical flicker frequency in minimal hepatic encephalopathy. Aliment Pharmacol Ther. 2013;37:527–536.
  • Luo M, Mu R, Liu JF, et al. Novel computerized psychometric tests as primary screening tools for the diagnosis of minimal hepatic encephalopathy. World J Clin Cases. 2020;8:3377–3389.
  • Metwally MA, Biomy HA, Omar MZ, et al. Critical flickering frequency test: a diagnostic tool for minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol. 2019;31:1030–1034.
  • Guzel A, Gunbey E, Koksal N. The performance of critical flicker frequency on determining of neurocognitive function loss in severe obstructive sleep apnea syndrome. J Sleep Res. 2017;26:651–656.
  • Ampuero J, Sim??N M, Montoli C, et al. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis. Gastroenterology. 2015;149:1483–1489.
  • Gregori B, Papazachariadis O, Farruggia A, et al. A differential color flicker test for detecting acquired color vision impairment in multiple sclerosis and diabetic retinopathy. J Neurol Sci. 2011;300:130–134.
  • Dahbour SS, Wahbeh AM, Hamdan MZ. Mini mental status examination (MMSE) in stable chronic renal failure patients on hemodialysis: The effects of hemodialysis on the MMSE score. A prospective study. Hemodial Int. 2009;13:80–85.
  • Kurella M, Chertow GM, Fried LF, et al. Chronic kidney disease and cognitive impairment in the elderly: The Health, Aging, and Body Composition study. JASN. 2005;16:2127–2133.
  • Kurella M, Chertow GM, Luan J, et al. Cognitive impairment in chronic kidney disease. J Am Geriatr Soc. 2004;52:1863–1869.
  • Bautovich A, Katz I, Loo CK, et al. Beck Depression Inventory as a screening tool for depression in chronic haemodialysis patients. Australas Psychiatry. 2018;26:281–284.
  • Beck AT, Guth D, Steer RA, et al. Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behaviour Res Ther. 1997;35:785–791.
  • Weissenborn K, Ennen JC, Schomerus H, et al. Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 2001;34:768–773.
  • Chillon JM, Massy ZA, Stengel B. Neurological complications in chronic kidney disease patients. Nephrol Dial Transplant. 2016;31:1606–1614.
  • Sánchez-Román S, Ostrosky-Solís F, Morales-Buenrostro LE, et al. Neurocognitive profile of an adult sample with chronic kidney disease. J Int Neuropsychol Soc. 2011;17:80–90.
  • Hannan M, Steffen A, Quinn L, et al. The assessment of cognitive function in older adult patients with chronic kidney disease: an integrative review. J Nephrol. 2019;32:211–230.
  • Jung S, Lee YK, Choi SR, et al. Relationship between cognitive impairment and depression in dialysis patients. Yonsei Med J. 2013;54:1447–1453.
  • Murtaza A, Dasgupta I. Chronic kidney disease and cognitive impairment. J Stroke Cerebrovasc Dis. 2020:105529.
  • Ali H, Soliman K, Mohamed MM, et al. The effects of dialysis modality choice on cognitive functions in patients with end-stage renal failure: a systematic review and meta-analysis. Int Urol Nephrol. 2021;53:155–163.
  • Tian X, Guo X, Xia X, et al. The comparison of cognitive function and risk of dementia in CKD patients under peritoneal dialysis and hemodialysis: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2019;98:e14390
  • Jhee JH, Lee E, Cha MU, et al. Prevalence of depression and suicidal ideation increases proportionally with renal function decline, beginning from early stages of chronic kidney disease. Medicine (Baltimore). 2017;96:e8476.
  • Das N, Wu X, Malhotra A. Regarding "uremic encephalopathy: MR imaging findings and clinical correlation". Am J Neuroradiol. 2017;38(3):E23–E24.